Clicky

Jiangsu Hengrui Medicine Co Ltd(600276)

Description: Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.


Keywords: Pharmaceutical Operating System Computer Architecture Linux

Home Page: www.hrs.com.cn

38 Huanghe Rd Eco & Tech Dev Park
Lianyungang, 222000
China
Phone: 86 518 8122 0983


Officers

Name Title
Mr. Jianjun Liu Financial Director
Ms. Su Mei Jiang Exec. Deputy GM & Director
Mr. Jie Ping Sun Deputy GM & Director
Mr. Hong Bin Dai Deputy GM & Director
Dr. Lian Shan Zhang Ph.D. Deputy GM & Director
Mr. Kai Hong Yuan Deputy Gen. Mang.
Mr. Ya Ping Shen Deputy Gen. Mang.
Mr. Xu Gen Sun Deputy Gen. Mang.
Mr. Wei Kang Tao Deputy Gen. Mang.
Mr. Cheng Liao Deputy Gen. Mang.

Exchange: SHG

Country: CN

Currency: Renminbi (¥)

Forward PE: 52.356
Trailing PE: 71.4
Price-to-Book MRQ: 6.7378
Price-to-Sales TTM: 11.1836
IPO Date: 2000-09-07
Fiscal Year End: December
Full Time Employees: 24491
Back to stocks